M90.60

Clinical Causes: Genetic factors: mutations in genes regulating bone growth, particularly the SQSTM1 gene. Environmental influences: possible exposure to certain infectious agents or environmental toxins, although these are less well-defined. Underlying neoplastic processes: the presence of certain tumors may influence or complicate bone disease, though the exact mechanisms are not fully understood. Age-related changes: more common in older adults, suggesting that age-related bone turnover may play a role.

Key Symptoms: Bone pain, often aching and localized. Bone deformities or enlargements, especially in the skull, spine, pelvis, or long bones. Fractures caused by weakened bone tissue. Muscle weakness due to altered biomechanics of affected bones. Headaches or hearing loss if skull bones are involved. Nerve compression symptoms if bone growth impinges on nerves.

Diagnosis Path: Diagnosing osteitis deformans in the context of neoplastic diseases involves a combination of clinical evaluation and specialized testing: - **Medical history and physical examination:** to assess symptoms and physical changes. - **Blood tests:** elevated serum alkaline phosphatase levels, which indicate increased bone turnover. - **Imaging studies:** X-rays reveal characteristic bone deformities and areas of increased density; bone scans can identify active sites; MRI may be used for detailed assessment. - **Bone biopsy:** sometimes necessary to differentiate from other bone pathologies or confirm neoplastic involvement. - **Additional tests:** laboratory assessment for associated neoplastic markers or other relevant diagnostic procedures based on suspected tumors. Accurate diagnosis is essential for assessing disease extent and planning appropriate management strategies.

Treatment Protocols: Treatment options aim to control symptoms, prevent complications, and address any underlying neoplastic process: - **Medications:** - Bisphosphonates are the primary drugs used to inhibit abnormal bone resorption, reducing pain and deformity. - Calcitonin may be used in some cases. - Analgesics for pain management. - **Addressing neoplastic disease:** specific therapies such as chemotherapy, radiotherapy, or targeted treatments depending on the type of cancer involved. - **Surgical intervention:** may be necessary to correct deformities, stabilize bones, or repair fractures. - **Regular monitoring:** to assess treatment efficacy and detect progression or complications. A multidisciplinary approach involving specialists in endocrinology, oncology, and orthopedics is often required to optimize care.